RESUMO
Bone marrow transplantation (BMT) may induce tolerance across xenogeneic barriers. We have established a xenogeneic BMT model where hamster BM is transplanted into splenectomized LEW rat recipients resulting in high levels of engraftment. Unfortunately, graft vs. host disease (GVHD) with severe dermatitis developed in all rat recipients. We were successful in treating or preventing the dermatitis of this xenogeneic GVHD by the use of the T-cell suppressant tacrolimus. However, this compound did not prevent the development of a fatal liver injury in the rat recipients. This study was designed to elucidate the pathogenesis of this liver injury appearing in T-cell suppressed rat recipients of hamster BM. Splenectomized and irradiated (10 Gy) LEW rats received 300 x 106 unfractionated hamster BM cells. These BMT recipients were divided in 3 groups: Group I recipients (n = 8) did not receive further immunosuppression. Group II animals (n = 10) received tacrolimus 1 mg/kg/d for 7 d. Group III recipients (n = 6) were given the same daily dose of tacrolimus on a long-term basis. Chimerism was detected by flow cytometry. Cytotoxicity of recipient's sera against rat and hamster lymph node cells was measured by complement-dependent cytotoxicity (CDC) test. Immunofluorescence was used to detect hamster antirat antibodies on several recipient organs. In Group I, 2 out of 8 animals engrafted (25%) and survived for a median of 21 d showing the severe dermatitis characteristic of GVHD. In group II (n = 10), 9/10 rat recipients engrafted (90%) and survival was increased to a median of 53.7 days. However, these surviving recipients developed fatal GVHD not different from that observed in Group I recipients. All animals in Group III (n = 6) engrafted and did not show the characteristic dermatitis of GVHD. Their survival, however, was shortened to a median of 30.3 d by a severe liver injury. This injury was characterized by hepatocyte necrosis in zones 1 and 2 with polymorphonuclear (PMN) cell infiltration. Deposits of hamster immunoglobulins were present around the necrotic areas and in the portal veins. Moreover, antirat antibodies appeared in the circulation. These antibodies were sensitive to dithiothreitol (DTT) treatment indicating that they were of the IgM class. This study shows that xenogeneic GVHD may have a dual presentation in the hamster-to-rat model: a classical cellular GVHD not distinct to the allogeneic one and a humoral GVHD affecting solely the recipient liver. The degree of humoral injury is potentiated by T-cell suppression.
Assuntos
Transplante de Medula Óssea/imunologia , Sobrevivência de Enxerto/imunologia , Doença Enxerto-Hospedeiro/imunologia , Transplante Heterólogo/imunologia , Animais , Cricetinae , Citometria de Fluxo , Terapia de Imunossupressão/métodos , Masculino , Ratos , Ratos Endogâmicos Lew , Esplenectomia , Tacrolimo/farmacologia , Quimeras de TransplanteAssuntos
Aorta/transplante , Antígenos CD28/imunologia , Antígenos CD40/imunologia , Rejeição de Enxerto/prevenção & controle , Animais , Apresentação de Antígeno , Aorta/patologia , Antígeno B7-1/imunologia , Ligante de CD40/imunologia , Doença Crônica , Rejeição de Enxerto/imunologia , Rejeição de Enxerto/patologia , Camundongos , Camundongos Endogâmicos C3H , Camundongos Endogâmicos C57BL , Transdução de Sinais , Transplante Homólogo , Túnica Íntima/patologiaAssuntos
Rejeição de Enxerto/imunologia , Doenças do Complexo Imune/imunologia , Transplante de Fígado/imunologia , Transplante Heterólogo/imunologia , Doença Aguda , Animais , Cricetinae , Imunoglobulina G/análise , Imunoglobulina M/análise , Terapia de Imunossupressão , Isoantígenos/imunologia , Nefropatias/imunologia , Nefropatias/patologia , Mesocricetus , Ratos , Ratos Endogâmicos LewAssuntos
Transplante de Fígado/imunologia , Linfócitos T/imunologia , Tolerância ao Transplante/imunologia , Triptofano Oxigenase/metabolismo , Triptofano/análogos & derivados , Triptofano/metabolismo , Animais , Inibidores Enzimáticos/farmacologia , Rejeição de Enxerto , Camundongos , Camundongos Endogâmicos C3H , Camundongos Endogâmicos C57BL , Linfócitos T/metabolismo , Transplante Homólogo , Triptofano/farmacologia , Triptofano Oxigenase/antagonistas & inibidoresAssuntos
Apresentação de Antígeno/imunologia , Aorta Torácica/transplante , Antígenos de Histocompatibilidade/imunologia , Túnica Íntima/patologia , Animais , Aorta Torácica/patologia , Antígeno B7-1/efeitos dos fármacos , Antígeno B7-1/imunologia , Antígenos CD28/efeitos dos fármacos , Antígenos CD28/imunologia , Antígenos CD40/efeitos dos fármacos , Antígenos CD40/imunologia , Ligante de CD40/efeitos dos fármacos , Ligante de CD40/imunologia , Camundongos , Camundongos Endogâmicos C3H , Camundongos Endogâmicos C57BLAssuntos
Antígenos de Diferenciação/uso terapêutico , Transplante de Medula Óssea/imunologia , Doença Enxerto-Hospedeiro/prevenção & controle , Imunoconjugados , Terapia de Imunossupressão/métodos , Imunossupressores/uso terapêutico , Transplante Heterólogo/imunologia , Abatacepte , Animais , Antígenos CD , Linfócitos B/imunologia , Antígeno CTLA-4 , Cricetinae , Doença Enxerto-Hospedeiro/imunologia , Ativação Linfocitária , Ratos , Ratos Endogâmicos Lew , Esplenectomia , Linfócitos T/imunologia , Fatores de Tempo , Irradiação Corporal TotalAssuntos
Transplante de Medula Óssea/imunologia , Doença Enxerto-Hospedeiro/imunologia , Terapia de Imunossupressão/métodos , Transplante Heterólogo/imunologia , Animais , Formação de Anticorpos , Cricetinae , Citotoxicidade Imunológica , Imunoglobulina G/análise , Imunoglobulina M/análise , Ratos , Ratos Endogâmicos Lew , Esplenectomia , Tacrolimo/uso terapêutico , Quimeras de Transplante , Irradiação Corporal TotalAssuntos
Bicarbonatos/sangue , Transplante de Fígado/fisiologia , Transplante Heterólogo/fisiologia , Animais , Dióxido de Carbono/sangue , Proteínas Inativadoras do Complemento/uso terapêutico , Venenos Elapídicos/uso terapêutico , Sobrevivência de Enxerto , Cobaias , Concentração de Íons de Hidrogênio , Imunossupressores/uso terapêutico , Transplante de Fígado/imunologia , Ácido Micofenólico/análogos & derivados , Ácido Micofenólico/uso terapêutico , Pressão Parcial , Ratos , Ratos Endogâmicos Lew , Tacrolimo/uso terapêutico , Transplante Heterólogo/imunologiaRESUMO
The objectives of this study were threefold: (i) assess immunogenicity of donor plasma proteins following hepatic xenotransplantation, (ii) identify potential immunogens, and (iii) consider the implications of antibody formation against these plasma proteins in xenograft survival. We studied liver and heart xenografts in a concordant combination, hamster to rat. All grafts were examined at necropsy for evidence of rat immunoglobulin G (IgG) deposition. Cardiac xenografts were placed in recipients who had, or had not, been sensitized with hamster serum. Hepatic xenografts were placed in naive recipients to see if antibodies to hamster serum proteins could be eluted from the rejecting organ. Sera of immunized rats were examined for the presence of anti-hamster antibodies by immunoelectrophoresis and by Western blotting following sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) separation of hamster serum. Antibodies in sera of immunized rats were compared with those eluted from rejecting livers. Candidate antigens were identified by tandem mass spectrometry, sequence analysis, and reference to protein databases. Results showed that sera of immunized rats recognized a minimum of four different antigens in hamster serum by immunoelectrophoresis, and a minimum of seven by the more sensitive SDS-PAGE Western blot. IgG eluted from rejecting livers bound three of seven candidate antigens recognized by sera of the immunized animals. Sequence analysis searches revealed proteinase inhibitors in each of the three SDS-PAGE bands common to the above samples. All of these candidate proteinase inhibitor immunogens share a common catabolic fate, uptake via the lipoprotein-related protein (LRP/alpha 2-macroglobulin receptor (CD91). Sensitization to hamster serum proteins hastened cardiac xenograft rejection in 30-50% of recipients (depending on sensitization protocol). Vascular deposition of rat IgG occurred in all rejecting xenografts. Antibody binding to proteinase inhibitors could disturb their functional activity and contribute to the pathogenesis of delayed xenograft rejection.
Assuntos
Proteínas Sanguíneas/imunologia , Epitopos/imunologia , Transplante de Fígado/imunologia , Transplante Heterólogo , Sequência de Aminoácidos , Animais , Anticorpos/análise , Anticorpos/sangue , Proteínas Sanguíneas/química , Western Blotting , Cricetinae , Epitopos/análise , Epitopos/química , Imunofluorescência , Rejeição de Enxerto/imunologia , Transplante de Coração/imunologia , Imunização , Imunoeletroforese , Imunoglobulina G/análise , Masculino , Espectrometria de Massas , Mesocricetus , Dados de Sequência Molecular , Ratos , Ratos Endogâmicos LewAssuntos
Transfusão de Sangue , Terapia de Imunossupressão/métodos , Transplante de Fígado/imunologia , Tacrolimo/farmacologia , Quimeras de Transplante/imunologia , Transplante Heterólogo/imunologia , Animais , Cricetinae , Sobrevivência de Enxerto/efeitos dos fármacos , Sobrevivência de Enxerto/imunologia , Imunossupressores/farmacologia , Teste de Cultura Mista de Linfócitos , Masculino , Mesocricetus , Ratos , Ratos Endogâmicos Lew , Baço/imunologiaRESUMO
Guinea-pig livers are poorly reperfused when transplanted into rats. We have observed that, in contrast to that of the rat, the guinea-pig intrahepatic portal vein (PV) has a thick layer of smooth muscle. It is possible that, after perfusion of the liver with ice-cold saline, this could go into spasm, resulting in poor reperfusion. To test this hypothesis, guinea-pig livers were perfused with different solutions stored at varying temperatures and transplanted into LEW rats. To prevent xenograft hyperacute rejection, all xenograft recipients were treated with 80 U/kg cobra venom factor (CVF) i.v. on days -1 and 0. In addition to the percentage reperfusion, PV resistance and recipient survival were also monitored. In group I, liver xenografts perfused with ice-cold saline (4 degrees C) reperfused poorly (20-30%), resulting in the development of portal hypertension (16.5 cmH2O vs. 12 cmH2O in naive LEW rats) and shortened mean survival time (11.7 +/- 4.2 h). In contrast, group II livers perfused with saline at room temperature (23 degrees C) underwent homogeneous reperfusion (98-100%) with no increase in portal vein resistance, indicating that low temperature was the main trigger for the spasm of the PV. Moreover, recipient survival in this group was significantly prolonged to a mean of 22 + 2.6 h (P < 0.01). Although UW solution (group III) and the vasodilator sodium nitroprusside (NP) (group IV) when used alone improved the degree of hepatic reperfusion, it was still not optimal. The supplementation, however, of UW solution with NP in group V animals resulted in homogeneous reperfusion (98%) with no portal hypertension and consistent prolonged graft survival of 21.0 +/- 1.7 h. Therefore, this study has determined that the riddle of the abnormal reperfusion of guinea-pig liver xenografts by rat blood is nonimmune mediated and is due to the spasm of the strong smooth muscle in the PV tree produced by cold perfusates.
Assuntos
Transplante de Fígado , Nitroprussiato , Soluções para Preservação de Órgãos , Reperfusão , Adenosina/imunologia , Adenosina/farmacologia , Alopurinol/imunologia , Alopurinol/farmacologia , Animais , Glutationa/imunologia , Glutationa/farmacologia , Cobaias , Insulina/imunologia , Insulina/farmacologia , Fígado/irrigação sanguínea , Fígado/patologia , Fígado/fisiopatologia , Masculino , Rafinose/imunologia , Rafinose/farmacologia , Ratos , Ratos Endogâmicos Lew , Reperfusão/métodos , Transplante HeterólogoRESUMO
BACKGROUND: In the acute rejection of allografts, the interaction between Fas (CD95) and its ligand (FasL; CD95L) has been shown to be involved in mediating apoptotic cell death. The role, however, of these molecules in the pathogenesis of transplant vascular sclerosis is as yet undetermined. The present study was therefore designed to address this issue. MATERIAL: C3H/HEJ FasLgld (FasL-; H2k) spontaneously mutant mice were used either as donors or recipients of aortic allografts; wild-type C57B1/6 (B6; H2b) were used as corresponding recipients or donors (n=6/group), respectively. Controls included aortas transplanted across appropriate allogeneic and syngeneic strain combinations. For histopathological evaluations, the grafts were harvested at day 40 after transplantation, at which time, splenocytes and sera were also obtained for mixed leukocyte reaction and complement-mediated microcytotoxicity assays, respectively. RESULTS: Similar to aortas obtained from allogeneic controls, allografts harvested from FasL- -->B6 recipients had morphological evidence of chronic rejection characterized by circumferential intimal thickening with partial disruption of the elastic membranes. Correspondingly, heightened antidonor cellular reactivity was also witnessed in these recipients. On the contrary, B6 allografts harvested from the majority of C3H-->FasL- recipients exhibited marked preservation of aortic morphology. Although these recipients had diminished antidonor cellular proliferation, the titers of alloantibodies were markedly elevated. CONCLUSION: The presence of FasL-expressing functional cytotoxic T cells is required for the pathogenesis of transplant vascular sclerosis. The significant reduction and/or absence of chronic rejection with the concomitant retention of antidonor humoral response in C3H FasL- recipients of B6 aortas prompt us to suggest that perhaps posttransplantation vasculopathy is initiated by cell-mediated cytotoxicity with its perpetuation facilitated by alloantibodies.
Assuntos
Aorta/transplante , Arteriosclerose/etiologia , Glicoproteínas de Membrana/fisiologia , Animais , Apoptose , Citotoxicidade Imunológica , Proteína Ligante Fas , Rejeição de Enxerto/etiologia , Rejeição de Enxerto/imunologia , Imuno-Histoquímica , Isoanticorpos/fisiologia , Ligantes , Teste de Cultura Mista de Linfócitos , Masculino , Glicoproteínas de Membrana/genética , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C3H , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos MRL lpr , Mutação Puntual , Receptor fas/fisiologiaAssuntos
Aorta/transplante , Antagonistas dos Receptores de Endotelina , Rejeição de Enxerto/fisiopatologia , Indanos/farmacologia , Transplante Homólogo/imunologia , Túnica Íntima/transplante , Animais , Aorta/imunologia , Aorta/patologia , Doença Crônica , Rejeição de Enxerto/patologia , Rejeição de Enxerto/prevenção & controle , Camundongos , Camundongos Endogâmicos C3H , Camundongos Endogâmicos C57BL , Receptor de Endotelina A , Túnica Íntima/imunologia , Túnica Íntima/patologiaAssuntos
Aorta/transplante , Apoptose/imunologia , Rejeição de Enxerto/imunologia , Glicoproteínas de Membrana/fisiologia , Transplante Homólogo/imunologia , Transplante Isogênico/imunologia , Receptor fas/fisiologia , Animais , Aorta/patologia , Doença Crônica , Proteína Ligante Fas , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C3H , Camundongos Endogâmicos C57BL , Transplante Homólogo/patologia , Transplante Isogênico/patologiaRESUMO
Aortic allotransplantation is a reliable procedure to study the evolvement of chronic rejection in mice. The progressive nature of this process in mice is characterized by diffuse and concentric myointimal proliferation which is inevitably associated with variable degrees of luminal constriction. These vascular changes are comparable to those that are witnessed in organ allografts undergoing chronic rejection in humans, underscoring its utility as a model of choice for the study of the development of this lesion. Whilst improved surgical technique has resulted in markedly enhanced graft survival, the results are far from being acceptable. Realizing this limitation, we embarked on developing a modified technique for aortic transplantation which would allow for improved graft survival in mice. A bypass conduit was created by end-to-side anastomosis of a segment of the donor's thoracic aorta into the infrarenal portion of the recipient's abdominal aorta. Using this technique, the graft survival was >98% with evidence in allotransplanted aorta of morphological changes pathognomonic of chronic rejection. On the contrary, no histopathological anomalies were discerned in aortic grafts transplanted across syngeneic animals. This modified surgical approach ameliorates the unacceptably high graft loss associated with earlier techniques, further extending the utility of this model as a tool to study the molecular and cellular mechanisms rudiment to the evolvement of chronic rejection.
Assuntos
Aorta Abdominal/cirurgia , Aorta Torácica/transplante , Anastomose Cirúrgica/métodos , Animais , Aorta Abdominal/patologia , Aorta Torácica/patologia , Doença Crônica , Modelos Animais de Doenças , Rejeição de Enxerto , Sobrevivência de Enxerto , Masculino , Camundongos , Transplante/métodos , Transplante HomólogoAssuntos
Ciclofosfamida/uso terapêutico , Sobrevivência de Enxerto/efeitos dos fármacos , Imunossupressores/uso terapêutico , Isoxazóis/uso terapêutico , Transplante de Fígado/imunologia , Ácido Micofenólico/análogos & derivados , Tacrolimo/uso terapêutico , Transplante Heterólogo/imunologia , Animais , Sinergismo Farmacológico , Sobrevivência de Enxerto/imunologia , Cobaias , Leflunomida , Transplante de Fígado/mortalidade , Ácido Micofenólico/uso terapêutico , Ratos , Ratos Endogâmicos Lew , Taxa de Sobrevida , Transplante Heterólogo/mortalidadeRESUMO
BACKGROUND: Human lymphokine-activated cells (LAK cells) and interferon alpha (IFN-alpha) have been used clinically in the therapy of posttransplant lymphoproliferative disease (PTLD). However, the efficacy of such therapy has not been extensively tested under controlled experimental conditions. METHODS: A B-cell line, derived from PTLD tissue and clonally related to the parent lesion, was tested for its response to IFN-alpha in vitro. The effects of LAK cells and IFN-alpha therapy were examined in a severe combined immunodeficiency disease (SCID) mouse model in vivo. RESULTS: The PTLD cell line studied showed a 30% decrease in the rate of growth upon incubation with 500 U/ml of IFN-alpha. This in vitro response was also reproduced in vivo, in tumor therapy studies conducted in SCID mice. The magnitude of this inhibitory effect in vivo was a function of tumor burden and dose of IFN-alpha. In parallel experiments, LAK cells reduced the tumorigenicity of a lymphoblastoid cell line derived from the peripheral blood of a patient with PTLD, and prolonged the survival of SCID-beige mice with established lymphoproliferative disease. In contrast with two prior studies, in which the use of autologous cytotoxic T cells was found to be necessary, we found the administration of third-party non-HLA-matched LAK cells also to be effective in reducing tumor burden. CONCLUSIONS: These observations demonstrate the efficacy of immunotherapy for lymphoproliferative disease under controlled experimental conditions, and validate currently ongoing efforts exploring the utility of such therapy in the clinical setting.
Assuntos
Hospedeiro Imunocomprometido/imunologia , Imunoterapia Adotiva , Interferon-alfa/farmacologia , Células Matadoras Ativadas por Linfocina , Transtornos Linfoproliferativos/etiologia , Transtornos Linfoproliferativos/terapia , Animais , Linfócitos B/efeitos dos fármacos , Linfócitos B/imunologia , Divisão Celular , Linhagem Celular , Ensaio de Imunoadsorção Enzimática , Humanos , Imunoglobulina M/imunologia , Interferon alfa-2 , Células Matadoras Ativadas por Linfocina/imunologia , Camundongos , Camundongos SCID , Proteínas RecombinantesRESUMO
Aortic allotransplantation in mice has been well established as a model of choice to study the evolvement of chronic rejection, the etiopathology of which is believed to be that of immune origin. This has prompted the postulation that prior induction of donor-specific tolerance would attenuate or abrogate the underlying events that culminate in posttransplant arteriosclerosis. To study the effects of donor-specific tolerance on chronic rejection, we performed orthotopic liver transplantation without immunosuppression in mice 30 days before aortic allotransplantation across C57Bl/ 10J (H2b)-->C3H (H2k) strain combinations (group III). Aortic allografting in syngeneic (group I; C3H-->C3H) and allogeneic (group II, C57Bl/10J-->C3H) animals served as controls. No morphological changes were evidenced in the transplanted aortas in group I animals. Contrarily, aortic allografts in group II animals underwent a self-limiting acute cellular rejection, which resolved completely and was succeeded by day 30 after transplantation by histopathological changes pathognomonic of chronic rejection. There was evidence for diffuse myointimal thickening, progressive concentric luminal narrowing, and patchy destruction of internal elastic membranes resulting in massive vascular obliteration by day 120 after transplantation. It was of interest that no arteriosclerotic changes were observed for the duration of follow-up (up to 120 days after transplantation) in transplanted aortas (liver donor-type) harvested from animals in group III. However, vasculopathy was prominent in third-party aortic grafts transplanted into tolerant recipients. Taken together, these data suggest that prior induction of tolerance abrogates the development of chronic rejection; this protection seems to be donor specific.
Assuntos
Aorta Torácica/transplante , Rejeição de Enxerto/prevenção & controle , Tolerância Imunológica/fisiologia , Condicionamento Pré-Transplante , Animais , Transplante de Fígado/imunologia , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C3H , Camundongos Endogâmicos C57BL , Transplante de Órgãos/patologia , Transplante de Órgãos/fisiologia , Fatores de TempoRESUMO
Liver transplantation is an immunological peculiarity with respect to the resistance of the graft to humoral rejection. We undertook a kinetic analysis of molecules involved in humoral rejection for a period of one week following xenografting in the hamster to rat model system. A complement-dependent lymphocytotoxicity test (CDC) was used to detect anti-donor antibodies in the recipient rats. Complement was studied by two methods. Function of the classical complement pathway was evaluated with a hemolytic assay, and C3 was measured by radial immunodiffusion. Conversion of the major plasma proteins from recipient to donor profile was studied by zone electrophoresis on agarose. CDC showed antibody titers rose during the first week post-transplantation, and they were of complement-activating isotypes. Zone electrophoresis showed almost complete replacement of rat C3 by hamster C3 within 72 hours. Hemolytic assay of complement on day 6 post-transplant showed serum of the xenograft recipients could lyse erythrocytes sensitized with rat antibody with 80% of efficiency of normal rat serum. Our data show the effector molecules for humoral rejection, rat antibodies with anti-hamster specificity and a functional complement cascade, were present within the first week following transplantation. Rapid conversion of serum complement to hamster proteins maintains compatibility with the species-specific membrane inhibitors of complement activation expressed by the xenografted hepatocytes, and could limit complement-mediated damage.